Price$1.36-0.06 (-4.23%)
03:30 PM07:45 PM
News · 26 weeks42+250%
2026-04-192026-10-11
Mix2890d
- SEC Filings14(50%)
- Other10(36%)
- Offering3(11%)
- Earnings1(4%)
Latest news
25 items- SECSEC Form F-3 filed by IM Cannabis Corp.F-3 - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form SCHEDULE 13G filed by IM Cannabis Corp.SCHEDULE 13G - IM Cannabis Corp. (0001792030) (Subject)
- PRIM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance SheetTransaction Expected to Result in an Improvement of Approximately C$3 Million in Shareholders' EquityVANCOUVER, BC and GLIL YAM, Israel, Sept. 29, 2026 /PRNewswire/ -- IM Cannabis Corp. (the "Company") (NASDAQ:IMCC), today announced that, further to its press releases dated June 18, 2026 and August 17, 2026, it has completed the previously announced transaction contemplated by the definitive share purchase agreement dated August 16, 2026 (the "Share Purchase Agreement") among the Company, Slil.com Holding Ltd. ("Slil") and I.M.C. Holdings Ltd. ("IMC Holdings"), pursuant to which the Company sold to Slil all of the issued and outstanding shares of IMC Holdings (the "Transaction"). The Transac
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common SharesVANCOUVER, BC and GLIL YAM, Israel, Sept. 24, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of its previously announced registered direct offering (the "Offering"), pursuant to which the Company sold and issued 655,000 common shares, no par value per share (the "Common Shares"), to certain accredited investors at a purchase price of US$2.00 per Common Share, resulting in aggregate gross proceeds to the Company of US$1.31 million, before deducting offering expenses. The Company intends to use the net proceeds from the Offering for working capital and general corporat
- SECSEC Form 424B5 filed by IM Cannabis Corp.424B5 - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Regains Compliance with Nasdaq Minimum Bid Price RequirementVANCOUVER and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced that on September 23, 2026, it received written notice from Nasdaq Stock Market LLC ("Nasdaq"), indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's ordinary shares was $1.00 per share or greater for the 18 consecutive business d
- PRIM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common SharesVANCOUVER, BC and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has entered into securities purchase agreements with certain accredited investors for the purchase and sale of 655,000 common shares, no par value per share, at a purchase price of US$2.00 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately US$1.31 million at closing before offering expenses. The closing of the offering is expected to occur on or about September 24, 2026, subject to the satisfaction of customary closing conditions. Th
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS MarketThe Company has entered a non-binding Letter of Intent to acquire control of Space Defense Innovations LLC, which is engaged in distributing BlueBird Aero Systems' advanced tactical UAS and unique Hybrid Fixed-Wing VTOL-UAS platforms in EuropeTORONTO and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (NASDAQ:IMCC), today announced that it has entered into a non-binding Letter of Intent (the "LOI") to acquire 51% of the issued and outstanding equity securities of Space Defense Innovations LLC, a Polish limited liability company ("SDI"), on a fully diluted basis. SDI, through its whol
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note FinancingTORONTO and GLIL YAM, Israel, Sept. 2, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender"). Pursuant to a note purchase agreement between the Company and Lender dated September 2, 2026 (the "September Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$225,000, with an original issuance discount of 10% (the "September Note").The September Note bears interes
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Shares Commence Trading on 30:1 Consolidated BasisTORONTO and GLIL YAM, Israel, Aug. 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the Company's common shares, no par value per share ("Common Shares"), commenced trading today on the Nasdaq Capital Market LLC ("Nasdaq") on a 30:1 post-consolidated basis (the "Consolidation"). The Company's existing trading symbol "IMCC" remains unchanged. The Company's new CUSIP and ISIN numbers are 44969Q505 and CA44969Q5059, respectively.After giving effect to the Consolidat
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price ComplianceTORONTO and GLIL YAM, Israel, Aug. 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares, no par value per share ("Common Shares") on the basis of one post-consolidated Common Share for every thirty pre-consolidated Common Shares (the "Consolidation"). The Board has authorized the Consolidation to be effected on or before September 15, 2026, with the Company currently expecting August 27, 2026 to
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused AssetsTransaction Expected to Result in an Improvement of Approximately CAD$3 million in Shareholders' EquityTORONTO and GLIL YAM, Israel, Aug. 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), today announced that, further to its press release dated June 18, 2026, it has entered into a definitive share purchase agreement dated August 16, 2026 (the "Share Purchase Agreement") with Slil.com Holding Ltd. ("Slil") and I.M.C. Holdings Ltd. ("IMC Holdings") pursuant to which the Company has agreed to sell to Slil all of the issued and outstanding shares of IMC Holdings (the "Transaction"). Prior to closing
- PRIM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial ResultsTORONTO and GLIL YAM, Israel, Aug. 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), today announced its financial results for the three and six months ended June 30, 2026. All amounts are reported in Canadian dollars, unless otherwise stated.Financial Summary for the Six Months Ended June 30, 2026Revenue of $16.3 million, compared to $25.2 million in the same period in 2025.Gross profit of $2.9 million, compared to $6.9 million in the same period in 2025.Operating loss of $3.8 million, compared to $0.2 million in the same period in 2025.Net loss of $6.9 million, or $0.85 per share (basic and di
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
IMCC FAQ
6 questionsWhat does IM Cannabis Corp. do?
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.Where does IMCC stock trade?
IM Cannabis Corp. (IMCC) is listed on NASDAQ.What sector and industry is IMCC in?
IM Cannabis Corp. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about IMCC?
IM Cannabis Corp. has had 3 recent analyst actions on file. The most recent action was from ROTH Capital: Buy with a $800.00 price target on 2021-10-05. Recent price targets range from $800.00 to $1050.00.What companies are similar to IMCC?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), DFTX (Definium Therapeutics Inc.). Compare IMCC side-by-side with any of them on Quantisnow.How can I track IMCC on Quantisnow?
Quantisnow aggregates IM Cannabis Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IMCC to receive live email and push alerts on every new disclosure.